Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic. (2020)
Attributed to:
MICA: Treatment According to Response in Giant cEll arTeritis (TARGET)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(20)30163-6
PubMed Identifier: 32835240
Publication URI: http://europepmc.org/abstract/MED/32835240
Type: Journal Article/Review
Volume: 2
Parent Publication: The Lancet. Rheumatology
Issue: 7
ISSN: 2665-9913